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Abstract
Background: Classical mammalian mitogen-activated protein kinase (MAPK) pathways consist of a cascade of three
successive phosphorylation events resulting in the phosphorylation of a variety of substrates, including another
class of protein kinases referred to as MAPK-activating protein kinases (MAPKAPKs). The MAPKAPKs MK2, MK3 and
MK5 are closely related, but MK2 and MK3 are the major downstream targets of the p38MAPK pathway, while MK5
can be activated by the atypical MAPK ERK3 and ERK4, protein kinase A (PKA), and maybe p38MAPK. MK2, MK3, and
MK5 can phosphorylate the common substrate small heat shock protein 27 (HSP27), a modification that regulates
the role of HSP27 in actin polymerization. Both stress and cAMP elevating stimuli can cause F-actin remodeling,
but whereas the in vivo role of p38MAPK-MK2 in stress-triggered HSP27 phosphorylation and actin reorganization is
well established, it is not known whether MK2 is involved in cAMP/PKA-induced F-actin rearrangements. On the
other hand, MK5 can phosphorylate HSP27 and cause cytoskeletal changes in a cAMP/PKA-dependent manner, but
its role as HSP27 kinase in stress-induced F-actin remodeling is disputed. Therefore, we wanted to investigate the
implication of MK2 and MK5 in stress- and PKA-induced HSP27 phosphorylation.
Results: Using HEK293 cells, we show that MK2, MK3, and MK5 are expressed in these cells, but MK3 protein levels
are very moderate. Stress- and cAMP-elevating stimuli, as well as ectopic expression of active MKK6 plus p38MAPK or
the catalytic subunit of PKA trigger HSP27 phosphorylation, and specific inhibitors of p38MAPK and PKA prevent this
phosphorylation. Depletion of MK2, but not MK3 and MK5 diminished stress-induced HSP27 phosphorylation, while
only knockdown of MK5 reduced PKA-induced phosphoHSP27 levels. Stimulation of the p38MAPK, but not the PKA
pathway, caused activation of MK2.
Conclusion: Our results suggest that in HEK293 cells MK2 is the HSP27 kinase engaged in stress-induced, but not
cAMP-induced phosphorylation of HSP27, while MK5 seems to be the sole MK to mediate HSP27 phosphorylation
in response to stimulation of the PKA pathway. Thus, despite the same substrate specificity towards HSP27, MK2
and MK5 are implicated in different signaling pathways causing actin reorganization.
Background
The mitogen-activated protein kinase (MAPK) pathways
control crucial cellular processes such as proliferation,
differentiation, cell survival, apoptosis, gene regulation,
and motility [1,2]. The typical mammalian MAPK path-
ways include the well-characterized MEK1-2/ERK1-2,
JNK1-3, MEK5/ERK5, and p38MAPK pathways, while the
atypical MAPK pathways include the less studied ERK3,
ERK4, and ERK7 [2-6]. The classical MAPK pathways
consist of a three partite module in which a MAPK
kinase kinase phosphorylates and activates downstream
MAPK kinases, which in turn phosphorylate and acti-
vate MAPK. MAPK can then phosphorylate non-protein
kinase substrates or yet other protein kinases. The latter
are referred to as mitogen-activated protein kinase-acti-
vating protein kinases (MAPKAPK) [1,2]. Based on
structural and functional homology, the MAPKAPKs are
divided in four subfamilies: ribosomal S6 kinase (RSK)
with the members RSK1-4; mitogen- and stress-acti-
vated kinase (MSK) comprising MSK1 and MSK2;
MAPK-interacting protein kinase (MNK) including
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MNK1 and MNK2, and the MAPK-activated protein
kinases (MAPKAPK) MK2, MK3 and MK5 [2-6]. Acti-
vation of the MEK1-2/ERK1-2 pathway is predominantly
triggered by growth factors and can lead to activation of
the RSKs and MSKs. The p38MAPK pathway, which is
induced by cellular stress stimuli and cytokines, can
activate MNK1/2, MSK1/2 and MK2, 3 and 5 [4-8].
MK5 is also a genuine substrate for the atypical MAPK
ERK3 and ERK4, but the stimuli triggering ERK3 and
ERK4 are unknown [9].
MK2, MK3 and MK5 are closely related, but MK2 and
MK3 are more identical to each other than to MK5 [6].
Cell culture experiments and studies with MK2, MK3,
and MK2/MK3 deficient mice have shown that MK2
and MK3 share physiological functions, including cyto-
kine production, endocytosis, architecture of the cytos-
keleton, cell migration, cell cycle control, chromatin
remodeling, and gene expression [10]. MK5-/- mice on a
mixed 129 × C57BL/6 genetic background appear nor-
mal, but are more susceptible to chemically-induced
skin cancer [11,12], while MK5 deficient mice on a
C57BL/6 genetic background display embryonic lethality
[13]. Despite their obvious distinct functions, MK2,
MK3, and MK5 share at least one known common sub-
strate, HSP27, which they can phosphorylate at serine
residues 15, 78, and 82 in vitro and in vivo [14]. How-
ever, the expression levels and activity of these three
kinases varies in different cell types, with MK2 more
abundantly expressed than MK3 in all cells examined
[10]. The relative concentrations of MK2 and MK5 have
not been systematically examined, but we found that the
relative MK2 protein levels are higher than those of
MK5 in HEK293 and HeLa cells (our unpublished
results). MK2 seems to be the primary target of
p38MAPK [6,15-17], and it is generally accepted that
MK2 is the major HSP27 kinase that phosphorylates
HSP27 and induces F-actin rearrangement in response
to cellular stress because overexpression of a dominant
negative MK2, depletion of MK2 by siRNA, MK2 inhibi-
tors, or knockout of MK2 abrogated stress-induced
HSP27 phosphorylation [11,18-23]. We have previously
shown that activation of the cAMP/PKA signaling path-
way triggers phosphorylation, activation, and nuclear
export of MK5 [24]. Furthermore we showed that a con-
stitutive active MK5 mutant that resides exclusively in
the cytoplasm can phosphorylate HSP27 at the relevant
phosphoacceptor sites Ser-78 and Ser-82 in vivo and is
sufficient to cause reorganization of the cytoskeleton
[24,25]. MK2 is not activated by PKA and is not
excluded from the nucleus after activation of the cAMP/
PKA pathway [24,25], suggesting that the PKA pathway
may utilize MK5 to induce phosphorylation of HSP27.
Here we demonstrate that stress-induced phosphoryla-
tion of HSP27 is mediated by p38MAPK-MK2, while
MK5, but not MK2, is implicated in PKA-triggered
HSP27 phosphorylation. These results indicate that
although MK2 and MK5 may play a role in a common
cellular process such as F-actin reorganization, they
operate in different pathways to do so.
Materials and methods
Materials
We used the adenylate cyclase activator forskolin from
both Enzo Life Sciences (Plymouth Meeting, PA, USA)
and from Sigma-Aldrich (St. Louis, MO, USA), while
the p38MAPK inhibitor SB203580 was purchased from
Enzo Life Sciences. The PKA inhibitor H89 was from
Bioaffin GmbH&Co KK (Kassel, Germany). Sodium
arsenite was obtained from Sigma-Aldrich. Recombinant
MK2, MK3 and MK5 were purchased from Invitrogen
Corporation (Carlsbad, CA, USA), while purified
Recombinant HSP27 with a C-terminal six histidine tag
was obtained from R&D Systems (Minneapolis, MN,
USA; cat. no. 1580-HS). Purified HSP27 with an N-
terminal GST tag was from SignalChem (Richmond,
Canada). Anti-HSP27 antibodies were purchased from
Millipore (Billerica, MA, USA; cat. no. MAB88051) and
Santa Cruz Biotechnology (Santa Cruz, CA, USA; cat.
no. sc-9012). MK2 and MK3 antibodies were from Cell
Signaling Technology (Danvers, MA, USA; cat. no. 3042
and 3043, respectively), while PRAK antibodies were
from Santa Cruz (cat. no. sc-46667). Phosphospecific
antibodies against phosphorylated HSP27 at serine 78,
and 82 were purchased from Millipore (cat. no. 04-447
and 04-448), Epitomics (cat. no. 1543-1 and 1118-1),
and Cell Signaling Technology (cat. no. 2405 and 2401).
PhosphoSer-15 Hsp27 antibody was from Cell Signaling
technology (cat. no. 2404) and Upstate Biotechnology
(Lake Placid, NY, USA; cat. no. 07-388). The phos-
phoMK2 Thr222 and Thr334 were both from Cell Sig-
naling Technology (cat. no. 3316 and 3007, respectively).
Expression plasmids for the catalytic subunit Ca of
PKA, EGFP-MK5, Flag-tagged HSP27, Flag-tagged
HSP27-3A, MKK6, and p38MAPK have been previously
described [24,29,31].
Cells
HEK293 cells (ATCC CRL-1573) were purchased from
the American Type Culture Collection (LGC Standards,
Boras, Sweden) and maintained in Eagle’s minimum
essential medium supplemented with 10% fetal calf
serum, 2 mM L-glutamine, penicillin (110 units/ml), and
streptomycin (100 μg/ml).
In vitro kinase assay
Phosphorylation of recombinant HSP27 by MK2, MK3,
and MK5 was performed in 25 mM Tris.HCl, pH 7.5;
10 mM MgCl2; 0.05 mg/ml BSA; 2.5 mM dithiothreitol;
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and 0.15 mM cold ATP in a total volume of 40 μl at 30°
C for 30 min. The reactions were stopped in 4xLDS
sample buffer and the proteins were denaturated at 70°C
for 10 min. The samples were then analyzed by polya-
crylamide gel electrophoresis (PAGE) and phosphoryla-
tion was monitored by western blotting using
phospospecific antibodies (see below).
Transfections
The day before transfection, 3×105 cells were seeded out
per well in a six-well plate. The next day, cells were
transfected with Lipofectamine 2000 (Invitrogen)
according to the manufacturer’s instructions. Scrambled
and siRNA directed against MK2, MK3 and MK5 were
purchased from Ambion, Applied Biosystems (Foster
City, CA, USA).
Western blotting
For detection of specific (phospho)proteins, samples
were analyzed by ClearPAGE 4-12% BisTris SDS-PAGE
(C.B.S. Scientific Company, Solana Beach, CA, USA) or
NuPage (Invitrogen Life Technologies) according to the
manufacturer’s protocol and blotted onto a 0.45-μm
polyvinylidene difluoride membrane (Millipore, Billerica,
MA). Incubation of the membrane with antibodies was
performed as previously described [24]. Briefly, the
membrane was blocked with PBS-T (PBS with 0.1%
Tween 20 (Sigma) containing 10% (w/v) dried skimmed
milk for 1 h and subsequently probed overnight at 4°C
with the primary antibody of choice. The next day, the
membrane was washed three times with PBS (or PBS-T
for the phospho-specific antibodies) and incubated with
the appropriate secondary antibody for 1 h at room
temperature. Visualization of proteins was achieved by
using CDPStar substrate (Tropix, Bedford, MA) and
Lumi-Imager F1 from Roche Applied Science. Magic-
Mark™ western standard from Invitrogen Life Technol-
ogies was used to estimate the molecular mass of the
detected proteins.
RNA isolation and reverse transcriptase polymerase chain
reaction (RT-PCR)
RNA was isolated from HEK293 cells using total RNA
isolation NucleoSpin® RNA II kit from Macherey-Nagel
(Düren, Germany) according to the manufacturer’s
instructions. The RNA concentration and purity were
checked by spectrometry using a Nanodrop ND-1000
(NanoDrop Technologies Inc., Wilmington, DE, USA).
Two μg of RNA was reversed transcribed using the
iScript cDNA synthesis kit (BioRad, Biocompare, San
Francisco, CA, USA) and subjected to PCR. To amplify
MK2, MK3, and MK5 cDNA following primers were
used: MK2 forward: GAATCTGTACGCAGGGAG-
GAAG; MK2 reverse: CATACTGGCCCATTCGGAT;
MK3 forward GTTGTCCAAGCAGGTGCTGGG,
MK3 reverse: TTAAGCACTGCGTCTTTCTCC; MK5
forward: CCCTACACTTACAACAAGAGCTGTG,
and MK5 reverse: CTTTATCTGTGAATCCACGAC-
CATTC. The primers for rRNA have been previously
described [33]. The PCR conditions were denaturation
at 94°C for 30 sec, annealing for 30 sec at 60°C, and
extension for 1 min at 72°C. For rRNA, 20 cycles were
run, while for MK2, MK3, and MK5, 30 cycles were
used. Amplicons of 479 bp (MK2), 420 bp (MK3), 691
bp (MK5) and 345 bp (rRNA) are obtained.
Densitometry
Densitometry was performed using a BioRad Model
GS-700 Imaging Densitometer and the Multi-Analyst
version 1.1 Software.
Results
MK2, MK3, and MK5 phosphorylate HSP27 in vitro at
serine residues 15, 78 and 82 but with different
stoichiometry
Previous studies have shown that activation of the
p38MAPK pathway induces phosphorylation of HSP27
and that p38MAPK downstream targets MK2, MK3, and
MK5, are genuine HSP27 kinases [7,14]. Moreover, we
have demonstrated that activation of the cAMP/PKA
pathway potentiates the kinase activity of MK5 [24].
The aim of this study was to examine whether activation
of the PKA pathway causes phosphorylation of HSP27
and to elucidate the involvement of MK2, MK3,
and MK5 in p38MAPK- and PKA-induced HSP27
phosphorylation.
The availability of specific antibodies against phospho-
Ser-15, phosphoSer-78, and phosphoSer-82 allows rapid
and convenient monitoring of HSP27 phosphorylation
at these sites in cells. To test the utility of these
phosphospecific antibodies, we examined commercially
available phosphoSer-15, phosphoSer-78, and phospho-
Ser-82 antibodies from different commercial sources
(see Table 1) to recognize in vitro phosphorylated
HSP27. Recombinant GST-HSP27 or His-tagged HSP27
were incubated with purified active MK2, MK3, or
MK5, respectively, and phosphorylation of Ser-15, -78,
and -82 was monitored by phosphospecific antibodies.
Increased in vitro phosphorylation, although with
Table 1 Sources of the commercially available
phosphoHSP27 specific antibodies used in this study.
antibody/source Millipore Epitomics CST* Upstate
phosphoSer-15 + +
phosphoSer-78 + + +
phosphoSer-82 + + +
*Cellular Signaling Technology
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different stoichiometry, could be detected at Ser-15, Ser-
78 and Ser-82 in the presence of MK2, MK3, and MK5
(Figure 1). The phosphorylation by MK5 was less potent
than by MK2 and MK3, despite the use of similar
amounts of MK2 (60 μg), MK3 (96 μg) and MK5 (90
μg) in our assay. We decided to use the phosphoSer-78
and phosphoSer-82 antibodies for our studies in cells.
HEK293 cells express different transcript and protein
levels of MK2, MK3 and MK5
Because we wanted to perform our studies in HEK293
cells, we examined the expression of MK2, MK3, and
MK5 at the RNA and protein level in these cells. Total
RNA was reverse transcribed and then amplified with
specific primers for MK2, MK3, and MK5. The relative
MK3 mRNA expression levels are less than those of
MK2 and MK5 (Figure 2A). This is in agreement with a
previous study that showed that MK2 transcript levels
detected by reverse transcription-PCR (RT-PCR) were
more abundant than those of MK3 [10]. Human MK2,
MK3, and MK5 have a molecular mass of 47 kD, 42 kD,
and 54 kD, respectively [6]. All three kinases were
expressed in these cells, but the protein levels of MK3
appeared lower than MK2 and MK5 (Figure 2B),
although it can be argued that differences may be due
to variable quality of the different antibodies. This is,
however, unlikely because another group using MK3
antibodies of a different commercial source made the
same observation [10]. Thus, both RT-PCR and western
blot assays confirm that MK2 and MK5 are more vividly
expressed than MK3.
Activated PKA pathway can trigger HSP27
phosphorylation
To test whether activation of the PKA pathway results
in phosphorylation of HSP27, Flag-tagged HSP27
Figure 1 Detection of phosphoHSP27 by different phosphospecific antibodies after in vitro phosphorylation with MK2, MK3, or MK5.
In vitro kinase assay was performed with either 200 ng recombinant GST-HSP27 (~52 kD; left and middle top panels) or histidine-tagged HSP27
(~28 kD; right top panel) in the presence of purified MK2 (60 μg), MK3 (96 μg), or MK5 (90 μg). Phosphorylation at the relevant phosphoacceptor
sites Ser-15, Ser-78, and Ser-82 was monitored by western blot using phosphospecific antibodies against phosphoSer-15 (Upstate), phosphoSer-
78 (Cell Signaling Technology), and phosphoSer-82 (Milipore). Top panel, left: phosphorylation at Ser-15; top panel middle: phosphorylation at
Ser-78; top panel right: phosphorylation at Ser-82. The presence of MK2, MK3, or MK5 was verified by western blot with anti-MK2, anti-MK3, and
anti-MK5 antibodies (middle panel). Equal loading of HSP27 was monitored with anti-HSP27 antibodies (bottom panel). M = protein molecular
mass marker (in kD).
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transfected HEK293 cells were treated with the cAMP
elevating agent forskolin and phosphorylation of HSP27
at Ser-78 and Ser-82 was monitored by western blot
using phosphoSer-78 and phosphoSer-82 specific anti-
bodies. Forskolin treatment resulted in >2-fold increase
in HSP27 phosphorylation at Ser-78 and Ser-82 (Figure
3A and 3B). Activation of the p38MAPK pathway by
sodium arsenite triggered HSP27 phosphorylation at
both sites (Figure 3A and 3B). Forskolin (respectively
arsenite) treatment enhanced phosphorylation of the
PKA substrate CREB (respectively phosphorylation of
p38MAPK), indicating that the stimuli were functional
(Figure 3A). In agreement with previous studies, arsenite
also caused CREB phosphorylation, probably through
MSK1 [4,8]. Pretreatment of the cells with the PKA spe-
cific inhibitor H89 reduced forskolin-induced HSP27
phosphorylation, indicating the involvement of PKA
(Figure 3B). The specific p38MAPK inhibitor SB203580
almost completely abrogated arsenite-induced HSP27
phosphorylation (Figure 3B). To provide further experi-
mental proof that PKA can mediate phosphorylation of
HSP27, we cotransfected cells with expression plasmids
for the catalytic subunit of PKA (Ca) and Flag-tagged
HSP27. Increased phosphorylation of endogenous and
Flag-tagged HSP27 was observed in cells ectopically
expressing PKA-Ca compared to cells transfected with
empty vector (compare lanes 1 and 2 in Figure 3C).
MK2 and MK5 contribute differently to stress- and
PKA-induced HSP27 phosphorylation
Our results suggest that PKA can mediate phosphoryla-
tion of HSP27 in cells, but the putative role of MK2,
Figure 2 Expression levels of MK2, MK3, and MK5 in HEK293 cells. (A) Total RNA was reverse transcribed and MK2, MK3, MK5, and rRNA
transcripts were amplified by PCR with specific primers. PCR products were visualized by electrophoresis on an agarose gel in the presence of
ethidium bromide. A size marker (in base-pairs; bp) was run on the gel to confirm the correct size of the PCR products. rRNA was used as an
internal control [33]. (B) The relative amounts of MK2, MK3, and MK5 in HEK293 cells was determined by western blotting. The band
corresponding to the molecular mass of MK2, MK3, and MK5 is indicated by an arrow. To assure equal sample loading, the blot was stripped
and re-probed with antibodies against actin. The molecular mass (in kD) of a protein marker is shown.
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MK3, and MK5 has not been addressed. On the other
hand, it is generally accepted that cellular stress triggers
HSP27 phosphorylation through the p38MAPK/MK2 sig-
naling pathway [26]. However, p38MAPK can also acti-
vate MK3 and MK5 [7], suggesting that these protein
kinases may also be implicated in stress-induced HSP27
phosphorylation. This prompted us to scrutinize a possi-
ble involvement of MK2, MK3, and MK5 in stress- and
PKA-induced HSP27 phosphorylation. The implication
of the MKs 2, 3 and 5 was tested by examining HSP27
phosphorylation in siRNA-treated cells. Transfection of
HEK293 cells with scrambled siRNA had no effect on
Figure 3 Activation of the p38MAPK and PKA pathways can provoke phosphorylation of HSP27. (A) HEK293 cells were transfected with an
expression vector for Flag-tagged HSP27 and 24 h after transfection left untreated (-) or exposed to forskolin (FSK; 10 μM for 30 min) or sodium
arsenite (SA; 250 μM for 30 min). The phosphorylation levels of phosphoSer-78 HSP27 were monitored. Equal loading was verified by examining
the total levels of HSP27 and actin in the samples. To ensure that the stimuli were active, phosphorylation of the PKA substrate CREB at Ser-133
and of the p38MAPK was tested. The double bands observed in the blots with (phospho)HSP27 antibodies represent Flag-tagged HSP27 (upper
band) and endogenous HSP27 (lower band). (B) HEK293 cells transfected with the Flag-HSP27 expression plasmid and cells were either left
untreated, exposed for 30 min with the PKA inhibitor H89 (10 μM) or the p38MAPK inhibitor SB203580 (10 μM) before forskolin or arsenite was
added, or were treated with forskolin or arsenite as described in (A). Lane 1: untreated Flag-Hsp27 transfected HEK293 cells; lane 2: stimulated
with forskolin; lane 3: stimulated with sodium arsenite; lane 4: exposed to H89; lane 5: pretreated with H89 and then stimulated with forskolin;
lane 6: pretreated with H89 and then stimulated with arsenite; lane 7: exposed to SB203580; lane 8: pretreated with SB203580 and then
stimulated with forskolin; lane 9: pretreated with SB203590 and then stimulated with arsenite. PhosphoSer78 HSP27 and phosphoSer82 HSP27
were examined. Membranes were stripped and the lysates were assayed for phosphorylation of CREB and p38MAPK. Lower panel shows the
expression levels of endogenous and Flag-tagged HSP27. (C) Cells were cotransfected with expression vectors for Flag-tagged HSP27 and the
catalytic subunit of PKA (Ca) or p38MAPK and a constitutive active mutant of its upstream activator MKK6 (MKK). PhosphoSer78 HSP27 protein
levels were examined by western blotting. M is the protein molecular mass (in kD) marker. RDU (relative densitometry units) indicates the
increase in HSP27 phosphorylation and was calculated as follows. The densitometry values obtained for the signals of phosphorylated HSP27
were determined and corrected for the values obtained for actin (in A) or for total HSP27 (in B). This ratio obtained for untreated cells was
arbitrarily set as 1.0 and the ratios obtained for stimulated cells were related to this. Values were calculated separately for flag-tagged HSP27 and
endogenous HSP27.
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the phosphoHSP27 levels after arsenite or forskolin
treatment (Figure 4A). Depletion of MK5 diminished
forskolin triggered HSP27 phosphorylation, but not
arsenite. Knockdown of MK2 strongly reduced arsenite-
triggered HSP27 phosphorylation, but did not affect
HSP27 phosphorylation caused by forskolin (Figure 4A).
Our results demonstrated no obvious effect on arsenite-
and forskolin-induced HSP27 phosphorylation in cells
with knockdown expression of MK3 (Figure 4B). An
additional experimental approach was used to explore
the possible role of MK2 in arsenite and forskolin-
induced HSP27 phosphorylation. While sodium arsenite
clearly triggered MK2 activation as monitored by phos-
phorylation of Thr-222 and Thr-334 [6,10], no MK2
phosphorylation was observed in cells exposed to for-
skolin (compare lanes 4 and 5 in the left panel of Figure
Figure 4 MK5 is implicated in PKA-induced HSP27 phosphorylation, while MK2 mediated p38MAPK-triggered HSP27 phosphorylation.
(A) Top panel: cells were transfected with scrambled siRNA (sc siRNA; lanes 2-4) or siRNA directed against MK5 (MK5 siRNA, lanes 4-6) or MK2
(lanes 7-9). After transfection, cells were left untreated (-, lanes 1, 4 and 7) or treated for 30 min with 250 μM sodium arsenite (SA, lanes 2, 5 and
8) or 10 μM forskolin (FSK, lanes 3, 6 and 9) and the cells were harvest. Protein levels were examined by western blot. Equal loading was verified
by examining the expression levels of actin. M = protein molecular mass marker (in kD). The intensity of the bands was determined by
densitometry and the value obtained for phosphorylated Flag-tagged-HSP27 (respectively phosphorylated endogenous HSP27) was arbitrary set
as 1.0 and the other values were related to this. A representative experiment is shown and similar results were obtained in two independent
experiments. Bottom panel: relative fold induction of HSP27 phosphorylation at Ser-78 in untreated and treated cells that had been transfected
with scrambled (sc) or MK5-targeting siRNA. The phosphoHSP27 levels in untreated, scrambled siRNA transfected cells were arbitrary set as 1.0.
The bars represent the average (+standard deviation) of three independent results. A significant difference (*p < 0.05; student’s t-test) was
observed for forskolin-induced HSP27 phosphorylation in scrambled siRNA and MK5-targeting siRNA transfected cells. (B) As in (A), but cells were
transfected with siRNA against MK3. RDU values were calculated as in (A). (C) Overexpression of active MKK6 plus p38MAPK (lane 3) or exposure
of cells to 250 μM sodium arsenite (SA) for 30 min (lane 5) causes phosphorylation of MK2, while the catalytic subunit of PKA (Ca) or forskolin
(FSK) failed to provoke HSP27 phosphorylation. Control cells were transfected with the empty expression vector pRcCMV (lane 1). The molecular
mass (in kD) of the protein marker is shown (lane M). The densitometry values obtained for the signals of phosphorylated HSP27 or MK5
(respectively MK2 or MK3) were determined and corrected for the values obtained for actin. RDU values in control cells (lanes 1) were arbitrarily
set as 1.0 and the other values were related to this.
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4C and lanes 2 and 3 in the middle panel of Figure 4C).
Similarly, MK2 phosphorylation was detected in cells
transfected with expression plasmids for active MKK6
plus p38MAPK, but not in cells transfected with the cata-
lytic subunit of PKA (compare lanes 2 and 3 in the left
panel of Figure 4C). Hence, these data indicate that
sodium arsenite, but not forskolin can activate the
HSP27 kinase MK2.
Taken together, these results indicate that MK2 is the
major HSP27 kinase in stress-induced cells, while MK5
mediates HSP27 phosphorylation upon activation of the
PKA pathway.
Discussion
HSP27 is a multifunctional protein and some of its
functions are regulated by phosphorylation mediated by
different pathways and protein kinases [14]. The MAP-
KAPK MK2, MK3, and MK5 can all phosphorylate
HSP27 in vitro and in vivo [14] and are downstream tar-
gets of p38MAPK [6,7], while MK5 can also be activated
by PKA [24,25]. However, the implication of MK5 in
p38MAPK- and PKA-induced HSP27 phosphorylation
remains incompletely explored. The aim of this study
was therefore to investigate the contribution of MK2,
MK3, and MK5 in p38MAPK- and PKA-trigger HSP27
phosphorylation.
MK3 is not a major HSP27 kinase in p38MAPK and PKA-
induced HSP27 phosphorylation
Although HSP27 was reported to be a good MK3 sub-
strate, at least in vitro [27], no HSP27 phosphorylation
was detected in MK2-/- mouse embryonic fibroblasts
(MEF) after p38MAPK activation [11]. This indicates that
MK3 does not detectably contribute to stress-induced
phosphorylation of HSP27 in MEF cells. In agreement
with the findings of Shi and his colleagues, we found
that depletion of MK3 did not affect HSP27 phosphory-
lation levels in HEK293 cells with activated p38MAPK or
PKA signaling pathways. The group of Gaestel found
lower expression levels and activity of MK3 compared
to MK2 in all cells tested [10]. We also observed much
lower MK3 transcript and protein levels than MK2 and
MK5 in HEK293 cells (Figure 2). The low protein levels
of MK3 may therefore explain the inferior or ignorable
activity of MK3 towards HSP27. We can, however, not
exclude a role for MK3 as a HSP27 kinase in other
pathways or other cells.
MK5, but not MK2 is implicated in PKA-induced HSP27
phosphorylation
Both MK2 and MK5 phosphorylated HSP27 at Ser-78
and Ser-82 in vitro, although with different stoichiome-
try (Figure 1). While MK2 could also phosphorylate Ser-
15, MK5 had only weak kinase activity towards this site.
This is in agreement with our previous study where we
failed to detect in vivo phosphorylation of this residue
by MK5 [25]. The in vitro results indicate that HSP27
may be a better substrate for MK2 or that the intrinsic
kinase activity of MK2 is higher than MK5. In agree-
ment with this assumption, the group of Matthias Gaes-
tel reported that immunoprecipitated MK5 from
arsenite-treated MEF cells had a 6-times lower activity
towards Praktide than MK2 immunoprecipitated from
arsenite-treated cells [11]. Our study confirms the domi-
nant role of MK2 in stress-induced phosphorylation of
HSP27, while MK5 does not seem to contribute in this
process. On the other hand, MK5, but not MK2 seems
to operate as the HSP27 kinase in response to activation
of the cAMP/PKA pathway. Recently, we reported that
PKA phosphorylates and activates MK5 in vitro [24],
while we and others had shown that MK5 can phos-
phorylate HSP27 in vivo [28,29]. However, our previous
results demonstrated that PKA enhanced the kinase
activity of MK5 only 2-fold [24]. The lower intrinsic
kinase activity of MK5 compared to MK2 and the weak
induction by PKA (2-fold) may explain why forskolin or
overexpression of the catalytic subunit of PKA only trig-
gered a moderate increase in HSP27 phosphorylation
compared to arsenite or active MKK6/p38MAPK.
MK2 does not participate in PKA-induced HSP27
phosphorylation in HEK293 cells, an assumption that is
underscored by our previous finding that PKA did not
phosphorylate MK2 [24]. Phosphorylation of MK5 at
Thr-182 by the p38MAPK pathway has been shown to be
necessary for activation in vitro [30,31], but the in vivo
interaction between p38MAPK and MK5 remains contro-
versial [7]. The role of MK5 as a genuine HSP27 kinase
in stress-treated cells has been jeopardized by the stu-
dies of Shi and co-workers [11]. These authors failed to
detect phosphoHSP27 in arsenite-treated MK2-/- MEF
cells, but not in MK5-/- MEFs. Moreover, they were
unable to phosphorylate recombinant HSP27 with
immunoprecipitated MK5. Our siRNA studies con-
firmed that MK5 is not involved in arsenite-induced
HSP27 phosphorylation (Figure 4A). The obvious expla-
nation why MK5 does not participate in p38MAPK-
induced HSP27 phosphorylation is that MK5 is not a
bona fide substrate for p38MAPK [7].
Our results demonstrate that MK5 is required,
whereas MK2 and MK3 appear dispensable for PKA-
induced HSP27 phosphorylation. The selectivity of PKA
for MK5 can be explained as follows. We have recently
demonstrated that Ser-115 is an in vitro PKA phos-
phoacceptor site and that ectopic expression of the
phosphomimicking MK5 S115D mutant resulted in
potent in vivo phosphorylation of HSP27, while the
MK5 S115A mutant was unable to do so [25]. Interest-
ingly, the corresponding Ser-115 residue is not
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conserved in MK2 (and MK3) and may explain why
PKA cannot activate MK2. Moreover we have shown
that MK5 and the catalytic Ca subunit of PKA can
form complexes in cells, while MK2 and Ca subunit
cannot be immunoprecipitated [24]. Hence MK5, but
not MK2 and MK3 may represent a substrate for PKA.
Both stress and cAMP elevating signals can cause F-
actin rearrangements [32]. Phosphorylation of HSP27
allows oligmerization of F-actin and cytoskeleton remo-
deling. The involvement of the p38MAPK-MK2-HSP27
pathway in F-actin rearrangements is well illustrated [6].
The PKA-MK5-HSP27 connection unveiled in this study
and our previous findings that active MK5 can induce
F-actin rearrangement in a HSP27-dependent manner
[29] may explain one mechanism for PKA-induced F-
actin reorganization.
We also showed that both the p38MAPK and the PKA
pathway can cause HSP27 phosphorylation at Ser-78
and Ser-82. We did not test phosphorylation at Ser-15
because the antibodies we used gave weak signals for
any of the three kinases using in vitro phosphorylated
HSP27. We were previously unable to detect HSP27
phosphorylation at Ser-15 in cells transfected with an
active MK5 mutant, although increased phosphorylation
on Ser-78 and Ser-82 was observed [29]. At present we
do not know whether MK5 can phosphorylate HSP27 at
Ser-15 in vivo or whether the failure to detect phos-
phorylation was the result of poor antibody quality.
Conclusions
In conclusion, we suggest that both MK2 and MK5 are
genuine HSP27 kinases that are engaged in different
pathways. While MK2 mediates phosphorylation of
HSP27 in response to stress-induced activation of the
p38MAPK pathway, MK5 seems to be involved in phos-
phorylation of HSP27 triggered by PKA (Figure 5).
Aberrant HSP27 phosphorylation levels have been
observed during viral infections, in diabetic kidney and
heart, and in diseases such as cancer, the autoimmune
diseases pemphigus vulgaris and pemphigus foliaceus,
and kidney fibrosis [14]. Hence, meticulous mapping of
the different pathways and protein kinases involved in
perturbed HSP27 phosphorylation in these clinical con-
ditions may allow the design of specific therapeutic
approaches to prevent abnormal phosphoHSP27 levels.
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